Canada markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3650+0.0950 (+4.19%)
At close: 04:00PM EDT
2.3510 -0.01 (-0.59%)
After hours: 05:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.94M
Enterprise Value -2.74M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.55
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-76.35%
S&P500 52-Week Change 329.57%
52 Week High 318.0000
52 Week Low 32.0200
50-Day Moving Average 32.5555
200-Day Moving Average 36.9397

Share Statistics

Avg Vol (3 month) 31.58M
Avg Vol (10 day) 349.32k
Shares Outstanding 51.71M
Implied Shares Outstanding 61.71M
Float 8969.87k
% Held by Insiders 115.06%
% Held by Institutions 12.59%
Shares Short (Mar 15, 2024) 440.25k
Short Ratio (Mar 15, 2024) 40.43
Short % of Float (Mar 15, 2024) 42.66%
Short % of Shares Outstanding (Mar 15, 2024) 42.36%
Shares Short (prior month Feb 15, 2024) 495.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 23, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 22, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-69.26%
Return on Equity (ttm)-178.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.59M
Net Income Avi to Common (ttm)-21.73M
Diluted EPS (ttm)-22.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.86M
Total Cash Per Share (mrq)5.57
Total Debt (mrq)171.52k
Total Debt/Equity (mrq)2.39%
Current Ratio (mrq)9.57
Book Value Per Share (mrq)5.82

Cash Flow Statement

Operating Cash Flow (ttm)-8.44M
Levered Free Cash Flow (ttm)-5.02M